| Cellular responses to proteasome inhibition: molecular mechanisms and beyond N Albornoz, H Bustamante, A Soza, P Burgos International Journal of Molecular Sciences 20 (14), 3379, 2019 | 50 | 2019 |
| Aberrant MUC1 accumulation in salivary glands of Sjögren’s syndrome patients is reversed by TUDCA in vitro I Castro, N Albornoz, S Aguilera, MJ Barrera, S González, M Nunez, ... Rheumatology 59 (4), 742-753, 2020 | 24 | 2020 |
| Impaired IRE1α/XBP-1 pathway associated to DNA methylation might contribute to salivary gland dysfunction in Sjögren’s syndrome patients D Sepúlveda, MJ Barrera, I Castro, S Aguilera, P Carvajal, C Lagos, ... Rheumatology 57 (6), 1021-1032, 2018 | 24 | 2018 |
| Novel insights into the non-canonical roles of PSMD14/POH1/Rpn11 in proteostasis and in the modulation of cancer progression HA Bustamante, N Albornoz, E Morselli, A Soza, PV Burgos Cellular signalling 101, 110490, 2023 | 8 | 2023 |
| Impaired IRE1 alpha/XBP-1 pathway associated to DNA methylation might contribute to salivary gland dysfunction in Sjogren's syndrome patients S González, C Molina, D Sepúlveda, MJ Barrera, I Castro, S Aguilera, ... OXFORD UNIV PRESS, 2018 | 1 | 2018 |
| AB0158 Tauroursodeoxycholic acid decreases the expression of erad components and the accumulation of salivary mucins induced by pro-inflammatory cytokines N Albornoz, S Aguilera, MJ Barrera, I Castro, P Carvajal, S González, ... Annals of the Rheumatic Diseases 76 (Suppl 2), 1102-1102, 2017 | 1 | 2017 |
| TUDCA reduces inflammatory markers in salivary gland cells decreasing MUC1 accumulation. A potential therapeutic agent to ameliorate inflammation in Sjogren's syndrome S Gonzalez, N Albornoz, MJ Barrera, S Aguilera, I Castro, U Urzua, ... CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 36 (3), S283-S283, 2018 | | 2018 |
| Impaired IRE1a/XBP-1 pathway associated to DNA methylation might contribute to salivary gland dysfunction in Sjogren’s syndrome patients D Sepulveda, MJ Barrera, I Castro, S Aguilera, P Carvajal, C Lagos, ... | | |
